- Home
- PYPD vs PED Comparison
PYPD vs PED Comparison
Compare PYPD & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- PED
- Stock Information
- Founded
- PYPD 2008
- PED N/A
- Country
- PYPD Israel
- PED United States
- Employees
- PYPD N/A
- PED N/A
- Industry
- PYPD Medical/Dental Instruments
- PED Oil & Gas Production
- Sector
- PYPD Health Care
- PED Energy
- Exchange
- PYPD Nasdaq
- PED Nasdaq
- Market Cap
- PYPD 60.4M
- PED 55.4M
- IPO Year
- PYPD 2020
- PED N/A
- Fundamental
- Price
- PYPD $3.63
- PED $0.58
- Analyst Decision
- PYPD Strong Buy
- PED Strong Buy
- Analyst Count
- PYPD 5
- PED 1
- Target Price
- PYPD $12.00
- PED $1.50
- AVG Volume (30 Days)
- PYPD 87.2K
- PED 229.9K
- Earning Date
- PYPD 11-12-2025
- PED 11-12-2025
- Dividend Yield
- PYPD N/A
- PED N/A
- EPS Growth
- PYPD N/A
- PED 569.41
- EPS
- PYPD N/A
- PED 0.14
- Revenue
- PYPD N/A
- PED $35,334,000.00
- Revenue This Year
- PYPD N/A
- PED N/A
- Revenue Next Year
- PYPD N/A
- PED $17.41
- P/E Ratio
- PYPD N/A
- PED $4.10
- Revenue Growth
- PYPD N/A
- PED 3.93
- 52 Week Low
- PYPD $2.30
- PED $0.47
- 52 Week High
- PYPD $3.93
- PED $1.00
- Technical
- Relative Strength Index (RSI)
- PYPD 53.80
- PED 47.05
- Support Level
- PYPD $3.59
- PED $0.56
- Resistance Level
- PYPD $3.88
- PED $0.65
- Average True Range (ATR)
- PYPD 0.15
- PED 0.04
- MACD
- PYPD 0.02
- PED -0.00
- Stochastic Oscillator
- PYPD 67.95
- PED 20.11
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.